SCYNEXIS to Present Commercial Launch Update for BREXAFEMME® (ibrexafungerp tablets)
Go back to SCYNEXIS to Present Commercial Launch Update for BREXAFEMME® (ibrexafungerp tablets)| (NASDAQ: AQST) | Delayed: 3.89 -0.15 (3.71%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.04 | 52 Week High | $ | |||
| Open | $4.01 | 52 Week Low | $ | |||
| Day High | $4.05 | P/E | N/A | |||
| Day Low | $3.86 | EPS | $ | |||
| Volume | 2,416,654 | |||||
| SCYNEXIS (NASDAQ: SCYX) | Delayed: 3.77 -0.09 (2.33%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.86 | 52 Week High | $7.29 | |||
| Open | $3.78 | 52 Week Low | $1.74 | |||
| Day High | $3.89 | P/E | N/A | |||
| Day Low | $3.67 | EPS | $0.00 | |||
| Volume | 117,788 | |||||



